NCT00595842

Brief Summary

This study retrospectively looks to determine the clinical success of ProRoot MTA used as an artificial apical barrier in teeth with immature apices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 7, 2008

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 16, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
Last Updated

March 8, 2012

Status Verified

March 1, 2012

Enrollment Period

1.3 years

First QC Date

January 7, 2008

Last Update Submit

March 7, 2012

Conditions

Keywords

Mineral trioxide aggregate

Study Arms (1)

Group one

Subjects are drawn from a search of all patients treated with MTA between ages 5-40

Eligibility Criteria

Age5 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients between 5-40 years old who have been treated with MTA

You may qualify if:

  • a tooth with a single canal and presence of an open apex by radiograph
  • Ca(OH)2 treatment for at least one week prior to obturation
  • use of MTA to produce an artificial apical barrier
  • placement of a final restoration
  • radiographs codumenting pretreatment and immedicate post-treatment conditionof the tooth
  • patients ages 5-40 years old

You may not qualify if:

  • patients younger than 5 and greater than 40 years old
  • patients unable to be contacted for recall during the study
  • patients with a medical condition whose health would be jeopardized by participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Health Science Center

San Antonio, Texas, 78229, United States

Location

MeSH Terms

Conditions

Tooth Abnormalities

Condition Hierarchy (Ancestors)

Stomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • David Holden, DMD

    University of Texas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair, Dept. of Endodontics

Study Record Dates

First Submitted

January 7, 2008

First Posted

January 16, 2008

Study Start

February 1, 2007

Primary Completion

June 1, 2008

Study Completion

June 1, 2008

Last Updated

March 8, 2012

Record last verified: 2012-03

Locations